Navigation Links
Shareholders Demand Philip Morris USA Stop Interfering in Health Policy
Date:5/28/2008

RICHMOND, Va., May 28 /PRNewswire-USNewswire/ -- At today's Altria (Philip Morris USA) annual meeting, shareholders demanded that the corporation stop lobbying against public health and tobacco control measures. America's largest tobacco corporation is opposing the Smuggled Tobacco Prevention (STOP) Act recently introduced in the U.S. House of Representatives (H.R. 5689), which contains new and stronger requirements on labeling, tracking and reporting by the tobacco industry.

This is the corporation's first annual meeting since it spun off its international tobacco business in March. PM USA executives are predicting that the split will reverse the revenue and operating profits decline of the last seven years.

"While executives continue to calculate how to build new fortunes for Philip Morris USA, our members continue to demand that the corporation stop promoting addictive, deadly products like Marlboro and Virginia Slims to our kids," said Tom Gaffney, spokesperson for Corporate Accountability International in a statement to Altria Chair and CEO Michael Szymanczyk.

On May 31, Gaffney's organization is joining the World Health Organization's (WHO) "World No Tobacco Day," which urges action to reverse a preventable epidemic that kills 5.4 million people each year. This year's event calls for a ban on tobacco advertising, promotion and sponsorship. Such a ban is one of the provisions of the WHO global tobacco treaty that now binds more than 150 countries.

The Bush Administration signed the global tobacco treaty four years ago, during the last U.S. Presidential election campaign, but has yet to submit it to the Senate for ratification.

"Big Tobacco's political influence is the single greatest obstacle to effective tobacco control policy in the U.S. and around the world," said Gaffney.

Prior to its breakup, in 2006 Philip Morris/Altria had three registered lobbyists in Washington for every five U.S. Senators. In the first
'/>"/>

SOURCE Corporate Accountability International
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Arrow International Urges Shareholders To Vote for Approval of the $45.50 Teleflex Inc. Merger and for the Current Board of Directors
2. Zimmer Holdings Offer and ORTHOsoft Directors Circular Mailed to Shareholders
3. Glass Lewis Recommends Arrow Shareholders Vote on the White Proxy Card for Merger With Teleflex and for Current Board of Directors at Arrow Annual Meeting
4. United Medicorp, Inc.s Shareholders Approve All Proposals
5. Arrow International Sends Letter Reminding Shareholders to Vote White Proxy Card in Support of Teleflex Merger and Election of Current Board of Directors
6. Proxy Governance Joins ISS, Glass Lewis and Egan Jones in Recommending Arrow International Shareholders Vote to Approve the $45.50 Per Share Merger With Teleflex
7. Arrow International, Inc. Invites You to Join Its 2007 Annual Meeting of Shareholders on the Web
8. Flextronics Shareholders and Solectron Stockholders Approve Acquisition
9. Healthcare Technologies to Reschedule the Shareholders Meeting to Approve the NexGen Biofuels Transaction
10. Lafley Tells Shareholders That P&G is Designed to Grow
11. Manor Care Shareholders Vote to Approve $6.3 Billion Carlyle Buyout
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2015)... (PRWEB) , ... August 30, 2015 , ... ... Ultrasound (HIFU) medical devices for the treatment of prostate cancer, has announced the ... this summer at the treatment center in Puerto Vallarta, Mexico. , The Sonablate® ...
(Date:8/29/2015)... ... August 29, 2015 , ... ... inventors from Miller Place, N.Y. "I specialize in manual therapy, and my invention ... it can be used for additional muscle dysfunction throughout the body." , They ...
(Date:8/29/2015)... NY (PRWEB) , ... August 29, 2015 , ... Next ... end of summer (which astronomically, officially ends on September 22nd this year). For IT ... cyber security hangovers linger on which could prove far more costly than a simple ...
(Date:8/29/2015)... ... 2015 , ... Vascular Health Sciences announced today that an ... HP, and that all claims and counterclaims have been irrevocably dismissed. , In ... the United States District Court for the Southern District of Texas for breach ...
(Date:8/28/2015)... ... August 28, 2015 , ... The Kentucky State Department of Workforce Investment ... position they are applying for, they are unable to pass the initial drug test ... drug testing policies in order to be able to hire long-term, skilled talent. (1) ...
Breaking Medicine News(10 mins):Health News:Image Fusion Technology Combines MRI and Ultrasound Images to Treat Prostate Cancer 2Health News:Inventors and InventHelp Clients Develops Tension Reliever (LGI-1951) 2Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 2Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 3Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 4Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 2Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 3Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 4
... MADISON - For the millions of Americans whose vision is ... lowly neural progenitor// cell may be riding to the rescue. ... derived from human fetal stem cells have been shown to ... to the kinds of diseases that afflict humans. The new ...
... Diabetes and high blood pressure, two conditions rooted in ... than race alone in determining// who is mostly likely ... from cardiologists at Johns Hopkins. Each year, nearly 300,000 ... ,Experts say that racial disparities have long been known ...
... lawmakers Monday it could be a decade or more before ... drugs // in the way the agency approves knockoffs of ... Janet Woodcock's testimony could benefit companies such as Amgen Inc. ... the U.S. for their products, some of the most complex ...
... blood thinner, one of the first signs the drug is ... and bruising,// an inconvenient side effect of preventing the blood ... stroke. While potentially life-saving, the drugs can also pose a ... of blood levels. ,So when he didn’t see ...
... disease causing tennis-ball-size ulcers so painful that victims feel ... than two years// become the second illness after smallpox ... and other preventive methods, the United Nations health agency ... of years of effort by local and international groups ...
... secretary said that computer based therapy will be available ... will be available to all patients in England from ... Beating the blues have been designed as therapies for ... warned that computer aided programs may not be suitable ...
Cached Medicine News:Health News:Stem Cell Therapy Shows Promise for Rescuing Deteriorating Vision 2Health News:Stem Cell Therapy Shows Promise for Rescuing Deteriorating Vision 3Health News:Who Gets Heart Failure? Race Takes Back Seat to Diabetes and High Blood Pressure 2Health News:Who Gets Heart Failure? Race Takes Back Seat to Diabetes and High Blood Pressure 3Health News:FDA Cites Challenges of Generic Biotech 2Health News:New Blood Thinner May Work Without Bleeding Risk 2Health News:Ancient Worm Disease Could Be Eradicated Within Two Years, UN Agency Reports 2Health News:Computer Based Therapy For Depression 2
(Date:8/27/2015)... FRANKLIN, Mass. , Aug. 27, 2015 /PRNewswire/ ... in the KSSTA Knee Journal, compared the Arthrosurface ... "inlay" Arthroplasty design, versus an "onlay" design implant ... showed similar improvements in function and pain scores, ... showed progression of osteoarthritis (OA). However, 53% of ...
(Date:8/27/2015)... Aug. 27, 2015 Biosimilars are not ... the U.S. Food and Drug Administration (FDA) for ... in its draft guidance issued today. The FDA,s ... proposes distinguishable names, calling for biological products to ... suffix. This proposal reflects the agency,s thinking that ...
(Date:8/27/2015)... , August 27, 2015 According to ... (Transfer, Hammock, Toilet, Seating, Universal, Standing, Bariatric ), Material (Nylon, Padded, ... Forecast to 2020", published by MarketsandMarkets, the Medical Lifting Sling Market ... 411.5 Million in 2015, at a CAGR of 11.4 % from ... ma rket data T ables and ...
Breaking Medicine Technology:Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 2Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 3Biologics Prescribers Collaborative (BPC) Statement on FDA Draft Guidance entitled "Nonproprietary Naming of Biological Products" 2Medical Lifting Sling Market Worth USD 706.0 Million by 2020 2Medical Lifting Sling Market Worth USD 706.0 Million by 2020 3Medical Lifting Sling Market Worth USD 706.0 Million by 2020 4
... Failed to Reach Statistical ... ... /PRNewswire-,FirstCall/ -- United Therapeutics Corporation (Nasdaq: UTHR ) and its,wholly- ... pivotal trials of OvaRex(R) MAb for the,treatment of advanced ovarian cancer. ...
... Cancer Patients, ROCKVILLE, Md., Dec. 4 ... company developing,therapeutics for the treatment of cancer and ... multi-center Phase 2 clinical trial with,MKC-1 in patients ... study will be to determine the antitumor activity ...
Cached Medicine Technology:Clinical Studies of OvaRex in Advanced Ovarian Cancer Fail to Meet Primary Endpoint 2Clinical Studies of OvaRex in Advanced Ovarian Cancer Fail to Meet Primary Endpoint 3Clinical Studies of OvaRex in Advanced Ovarian Cancer Fail to Meet Primary Endpoint 4EntreMed Commences Phase 2 Study with MKC-1 in Pancreatic Cancer 2EntreMed Commences Phase 2 Study with MKC-1 in Pancreatic Cancer 3EntreMed Commences Phase 2 Study with MKC-1 in Pancreatic Cancer 4
... VasoSeal VHD was the ... stop bleeding after diagnostic ... radiology procedures. It is ... device approved for immediate ...
... Hemostats First Stop absorbable collagen hemostat. FirstStop ... superior handling and removal characteristics. It can ... to fit the wound. FirstStop products are ... be peeled away after hemostasis is achieved. ...
The VasoSeal Low Profile device is designed for smaller sheath angiography procedures. VasoSeal Low Profile. Seal your arterial punctures with confidence....
The VasoSeal Low Profile device is designed for smaller sheath angiography procedures. VasoSeal Low Profile. Seal your arterial punctures with confidence....
Medicine Products: